Nippon Shinyaku Co., Ltd.
Research Nippon Shinyaku Co., Ltd. (4516.T) on Bullrun: market cap JPY 232.33B, P/E 7.2, dividend yield 3.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4516.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 232.33B
- P/E7.2
- Dividend yield3.6%
- Financial periodFY2026
- RevenueJPY 170.77B
- Revenue growth6.6%
- Net incomeJPY 29.72B
- Free cash flowJPY 23.44B
- Gross margin66.4%
Valuation Snapshot
latest market cap is JPY 232.33B; P/E is 7.2; dividend yield is 3.6%.
Peer valuation comparison
Latest P/E is 7.22x versus a Healthcare sector median of 21.69x (66.7% below).
Latest dividend yield is 3.61% versus a Healthcare sector median of 2.41% (49.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 170.77B | JPY 29.72B | JPY 23.44B | 66.4% | 441 | JPY 76.59B | JPY 2.57B | JPY 291.55B |
| FY2025 | JPY 160.23B | JPY 32.56B | JPY 1.33B | 68.1% | 483.26 | JPY 55.24B | JPY 2.72B | JPY 247.03B |
| FY2024 | JPY 148.26B | JPY 25.85B | JPY 6.64B | 66.1% | 383.82 | JPY 58.09B | JPY 2.87B | JPY 220.22B |
| FY2023 | JPY 144.18B | JPY 22.81B | JPY 14.44B | 61.2% | 338.7 | JPY 60.05B | JPY 2.66B | JPY 195.62B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 232.33B | 7.2 | 3.6% | 124 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 124 JPY, yield 3.6%.
| Year | Dividends/share |
|---|---|
| FY2026 | 124 JPY |
| FY2025 | 124 JPY |
| FY2024 | 124 JPY |
| FY2023 | 119 JPY |
About Nippon Shinyaku Co., Ltd.
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Atthena Therapeutics, Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Nippon Shinyaku Co., Ltd.'s market cap?
Nippon Shinyaku Co., Ltd.'s market capitalization is JPY 232.33B.
What is Nippon Shinyaku Co., Ltd.'s P/E ratio?
Nippon Shinyaku Co., Ltd.'s price-to-earnings (P/E) ratio is 7.2.
Does Nippon Shinyaku Co., Ltd. pay a dividend?
Nippon Shinyaku Co., Ltd. has a dividend yield of 3.6%.
What does Nippon Shinyaku Co., Ltd. do?
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Atthena Therapeutics, Inc.